Dr. Cathy Spillane gained a joint honours degree in Pharmacology and Genetics in 2005 from University College Dublin (UCD), Ireland. She went on to obtain one of six places on the Health Research Board Ph.D. Studentship. Her Ph.D. examined the effect of molecularly targeting the HPV viral oncogene and oncoprotein in cervical cancer and was conducted through the Department of Clinical Medicine in Trinity College Dublin (TCD), Ireland. She was awarded a Ph.D. for her thesis on this research in 2010. Dr. Spillane is currently a Post Doctoral Research Fellow in Department of Histopathology in TCD. Her research centres on the use of functional genomics to understand the molecular basis of the development of cancer and how this knowledge can be translated to improve diagnosis and treatment. Much of her recent work has focused on the biology of circulating tumour cells, with a specific emphasis on ovarian cancer, and establishing their diagnostic and prognostic potential, through the development of a novel point of care device in collaboration with the Biomedical Diagnostic Institute (BDI) in Dublin City University (DCU). She has presented at both national and international conferences and published in peer-reviewed journals, including PLoS One and Lab on a Chip.
Department of Histopathology
Trinity College Dublin